We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$259M
AUM Growth
+$8.14M
Cap. Flow
+$1.18M
Cap. Flow %
0.45%
Top 10 Hldgs %
57.78%
Holding
1,585
New
87
Increased
403
Reduced
192
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 7.44%
3 Healthcare 4.71%
4 Communication Services 2.97%
5 Consumer Discretionary 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOTZ icon
626
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
$24K 0.01%
1,200
CINF icon
627
Cincinnati Financial
CINF
$27.1B
$24K 0.01%
234
+21
+10% +$2.02K
CLH icon
628
Clean Harbors
CLH
$16.3B
$24K 0.01%
349
DELL icon
629
Dell
DELL
$293B
$24K 0.01%
945
EC icon
630
Ecopetrol
EC
$34.5B
$24K 0.01%
1,315
FBIN icon
631
Fortune Brands Innovations
FBIN
$6.06B
$24K 0.01%
495
FTI icon
632
TechnipFMC
FTI
$27.3B
$24K 0.01%
1,292
+144
+13% +$2.52K
IFF icon
633
International Flavors & Fragrances
IFF
$21.9B
$24K 0.01%
170
LNT icon
634
Alliant Energy
LNT
$18B
$24K 0.01%
508
+53
+12% +$2.53K
LVS icon
635
Las Vegas Sands
LVS
$29.6B
$24K 0.01%
412
+38
+10% +$2.35K
NBR icon
636
Nabors Industries
NBR
$1.21B
$24K 0.01%
166
-13
-7% -$2.08K
RJF icon
637
Raymond James Financial
RJF
$34B
$24K 0.01%
438
WYNN icon
638
Wynn Resorts
WYNN
$10.6B
$24K 0.01%
196
HZNP
639
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$24K 0.01%
1,000
AAP icon
640
Advance Auto Parts
AAP
$3.49B
$23K 0.01%
153
AIZ icon
641
Assurant
AIZ
$14.3B
$23K 0.01%
218
AVA icon
642
Avista
AVA
$3.24B
$23K 0.01%
518
FFIV icon
643
F5
FFIV
$22.7B
$23K 0.01%
162
IDA icon
644
Idacorp
IDA
$8.2B
$23K 0.01%
230
IDXX icon
645
Idexx Laboratories
IDXX
$46.2B
$23K 0.01%
87
+8
+10% +$1.97K
LFUS icon
646
Littelfuse
LFUS
$11.6B
$23K 0.01%
132
+14
+12% +$2.54K
MASI
647
DELISTED
Masimo
MASI
$23K 0.01%
158
TEVA icon
648
Teva Pharmaceuticals
TEVA
$41.2B
$23K 0.01%
2,526
+37
+1% +$446
TRI icon
649
Thomson Reuters
TRI
$44.1B
$23K 0.01%
340
WLKP icon
650
Westlake Chemical Partners
WLKP
$763M
$23K 0.01%
940
-70
-7% -$1.62K

Similar funds

Lindbrook Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Lindbrook Capital held 1,585 positions worth $259M, up 3.2% from $251M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Lindbrook Capital's Q2 2019 filing shows 87 new, 403 increased, 192 reduced and 88 closed positions. Its largest new stake was Carlyle Secured Lending: 11,133 shares worth $169K. The largest sale was Vanguard Morningstar Total Stock Market ETF, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q2 2019 buy was Carlyle Secured Lending: 11,133 shares worth $169K.
  • Lindbrook Capital added most to CME Group in Q2 2019, an estimated $2.47M increase.
  • Lindbrook Capital's biggest Q2 2019 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $1.44M.
  • Lindbrook Capital fully exited Box in Q2 2019, selling an estimated $820K.
  • Lindbrook Capital's ten largest holdings make up 58% of its $259M portfolio in Q2 2019.
  • Lindbrook Capital opened 87 new positions and closed 88 in Q2 2019.
  • Lindbrook Capital's portfolio value rose 3.2% quarter-over-quarter to $259M.

Based on Lindbrook Capital's 13F filing for Q2 2019, filed 24 Jul 2019.